18276079|t|Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
18276079|a|A disintegrin and metalloprotease (ADAM) 10 is the main candidate enzyme for the alpha-secretase processing of the amyloid precursor protein (APP). Neuron-specific ADAM10 overexpression proved beneficial in the APP[V717I] mutant Alzheimer mouse model [Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113:1456-1464]. Since Alzheimer patients have a high prevalence for epileptic seizures, we investigated the effects of ADAM10 modulation under conditions of experimentally induced epileptic seizures. In this context we also examined whether ADAM10 effects were influenced by APP levels. Therefore we compared severity of kainate-induced seizures, neurodegeneration and inflammation in double transgenic mice overexpressing functional ADAM10 or a dominant negative ADAM10 mutant in the APP[V717I] background with single transgenic ADAM10 modulated mice. Double transgenic dominant negative ADAM10dn/APP[V717I] mice suffered from stronger epileptic seizures, had a longer recovery period and showed more neurodegeneration and glial activation in the hippocampal region than double transgenic mice moderately overexpressing functional ADAM10 (ADAM10mo/APP[V717I]) and APP[V717I] mice with endogenous ADAM10 levels. This suggests that ADAM10 activity is necessary to provide neuroprotection against excitotoxicity in the APP[V717I] mouse model. Interestingly, increased expression of functional ADAM10 above the endogenous level did not correlate with a better protection against seizures and neurodegeneration. Furthermore, ADAM10 dominant negative mice without transgenic APP overexpression (ADAM10dn) were seizing for a shorter time and showed less neuronal cell death and neuroinflammation after kainate injection than wild-type mice, which shows beneficial effects of ADAM10 inhibition in context with neurodegeneration. In contrast, mice with a high ADAM10 overexpression showed more seizures and stronger neuronal damage and inflammation than wild-type mice and mice with moderate ADAM10 overexpression. Hence, additional cleavage products of ADAM10 may counterbalance the neuroprotective effect of alpha-secretase-cleaved APP in the defense against excitotoxicity. Our findings highlight the need of a careful modulation of ADAM10 activity for neuroprotection depending on substrate availability and on neurotoxic stress conditions.
18276079	27	33	ADAM10	Gene	11487
18276079	74	85	excitotoxic	Disease	
18276079	94	137	A disintegrin and metalloprotease (ADAM) 10	Gene	11487
18276079	209	234	amyloid precursor protein	Gene	11820
18276079	258	264	ADAM10	Gene	11487
18276079	309	314	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127791
18276079	323	332	Alzheimer	Disease	MESH:D000544
18276079	333	338	mouse	Species	10090
18276079	561	568	amyloid	Disease	MESH:C000718787
18276079	590	601	hippocampal	Disease	MESH:D000092223
18276079	616	633	Alzheimer disease	Disease	MESH:D000544
18276079	634	639	mouse	Species	10090
18276079	683	692	Alzheimer	Disease	MESH:D000544
18276079	693	701	patients	Species	9606
18276079	729	747	epileptic seizures	Disease	MESH:D004827
18276079	780	786	ADAM10	Gene	11487
18276079	841	859	epileptic seizures	Disease	MESH:D004827
18276079	902	908	ADAM10	Gene	11487
18276079	982	989	kainate	Chemical	MESH:D007608
18276079	998	1006	seizures	Disease	MESH:D012640
18276079	1008	1025	neurodegeneration	Disease	MESH:D019636
18276079	1030	1042	inflammation	Disease	MESH:D007249
18276079	1064	1068	mice	Species	10090
18276079	1095	1101	ADAM10	Gene	11487
18276079	1125	1131	ADAM10	Gene	11487
18276079	1150	1155	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127791
18276079	1191	1197	ADAM10	Gene	11487
18276079	1208	1212	mice	Species	10090
18276079	1263	1268	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127791
18276079	1270	1274	mice	Species	10090
18276079	1298	1316	epileptic seizures	Disease	MESH:D004827
18276079	1363	1380	neurodegeneration	Disease	MESH:D019636
18276079	1409	1420	hippocampal	Disease	MESH:D000092223
18276079	1451	1455	mice	Species	10090
18276079	1493	1499	ADAM10	Gene	11487
18276079	1514	1519	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127791
18276079	1530	1535	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127791
18276079	1537	1541	mice	Species	10090
18276079	1558	1564	ADAM10	Gene	11487
18276079	1592	1598	ADAM10	Gene	11487
18276079	1656	1670	excitotoxicity	Disease	
18276079	1682	1687	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127791
18276079	1689	1694	mouse	Species	10090
18276079	1752	1758	ADAM10	Gene	11487
18276079	1837	1845	seizures	Disease	MESH:D012640
18276079	1850	1867	neurodegeneration	Disease	MESH:D019636
18276079	1882	1888	ADAM10	Gene	11487
18276079	1907	1911	mice	Species	10090
18276079	2009	2028	neuronal cell death	Disease	MESH:D009410
18276079	2033	2050	neuroinflammation	Disease	MESH:D000090862
18276079	2057	2064	kainate	Chemical	MESH:D007608
18276079	2090	2094	mice	Species	10090
18276079	2130	2136	ADAM10	Gene	11487
18276079	2164	2181	neurodegeneration	Disease	MESH:D019636
18276079	2196	2200	mice	Species	10090
18276079	2213	2219	ADAM10	Gene	11487
18276079	2247	2255	seizures	Disease	MESH:D012640
18276079	2269	2284	neuronal damage	Disease	MESH:D009410
18276079	2289	2301	inflammation	Disease	MESH:D007249
18276079	2317	2321	mice	Species	10090
18276079	2326	2330	mice	Species	10090
18276079	2345	2351	ADAM10	Gene	11487
18276079	2407	2413	ADAM10	Gene	11487
18276079	2514	2528	excitotoxicity	Disease	
18276079	2589	2595	ADAM10	Gene	11487
18276079	2668	2678	neurotoxic	Disease	MESH:D020258
18276079	Association	MESH:D000544	RS#:63750264;HGVS:p.V717I;CorrespondingGene:351
18276079	Association	MESH:D004827	RS#:63750264;HGVS:p.V717I;CorrespondingGene:351
18276079	Positive_Correlation	MESH:D007608	MESH:D007249
18276079	Association	MESH:D007249	11487
18276079	Association	MESH:D019636	11487
18276079	Association	11487	11820
18276079	Positive_Correlation	MESH:D007608	MESH:D012640
18276079	Association	MESH:D000544	11487
18276079	Positive_Correlation	MESH:D007608	MESH:D019636
18276079	Association	MESH:D000544	351
18276079	Association	MESH:D004827	351

